financetom
Business
financetom
/
Business
/
EHang, Enpower Team Up On Next-Gen eVTOL Tech: Details
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
EHang, Enpower Team Up On Next-Gen eVTOL Tech: Details
Nov 11, 2024 6:18 AM

EHang Holdings Limited ( EH ) shares are trading higher premarket on Monday. The company disclosed a long-term strategic partnership with Zhuhai Enpower Electric Co., Ltd.

The collaboration will focus on co-developing high-performance electric motors and motor controllers for EHang’s electric vertical take-off and landing (eVTOL) aircraft.

The collaboration aims to develop customized electric motor drive systems tailored to the specific needs of EHang’s eVTOL products and the stringent airworthiness standards set by civil aviation authorities.

This partnership will boost the performance and reliability of EHang’s eVTOL aircraft to meet the growing demands of the industry.

Huazhi Hu, EHang’s Founder, Chairman and Chief Executive Officer, said, “This strategic partnership with Enpower not only validates our vision but also provides the necessary impetus for our goals. Together, we will redefine the future of transportation, making it safer, more efficient, and environmentally friendly.”

”We look forward to the collaboration with more partners from upstream and downstream in the UAM sector and the achievements that lie ahead.”

Last week, EHang’s EH216-S eVTOL aircraft successfully completed debut passenger flights in Bangkok, Thailand, marking the company’s expansion into its 18th country.

With approval from the Civil Aviation Authority of Thailand, EHang ( EH ) plans flight tests and aims to launch commercial operations in regions like Phuket and Koh Samui by 2025, further developing Thailand’s air mobility market.

Investors can gain exposure to the stock via SPDR S&P Kensho Smart Mobility ETF ( HAIL ) and SPDR S&P Kensho New Economies Composite ETF ( KOMP ) .

Price Action: EH shares are up 3.15% at $17.03 premarket at the last check Monday.

Read Next:

Chinese EV Maker BYD Edges Closer To Ford’s Sales Volume After Beating Tesla In Revenue Race

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
What's Going On With Longeveron Stock?
What's Going On With Longeveron Stock?
Apr 15, 2024
Longeveron Inc ( LGVN ). shares are trading higher Monday following insider buys from multiple company executives. Here's a look at what's going on. What To Know: Multiple company executives disclosed large stock purchases after the close on Friday. Joshua Hare, Chief Scientific Officer, purchased 297,872 shares. Rock Soffer, director, purchased 276,596 shares and CEO Mohamed Wa’el Ahmed Hashad purchased...
Tesla's senior battery executive exits company
Tesla's senior battery executive exits company
Apr 15, 2024
April 15 (Reuters) - Tesla's senior vice president of powertrain and energy engineering, Drew Baglino, is leaving after 18 years at the auto-maker, he said in a post on social media site X on Monday. Tesla's vice president of public policy and business development, Rohan Patel, has also left the carmaker, according to a post on X by a Bloomberg...
Evercore strategists back dour S&P 500 view, expect weaker earnings outlook
Evercore strategists back dour S&P 500 view, expect weaker earnings outlook
Apr 15, 2024
NEW YORK (Reuters) - U.S. earnings estimates are likely to weaken as companies issue cautious outlooks, according to Evercore ISI strategists, who stood by their view the S&P 500 will end the year well lower than current levels. As first-quarter reporting season gets underway, 30 S&P 500 companies have posted results so far with a 6% earnings beat, according to...
Marinus Pharmaceuticals Shares Fall After Phase 3 Trial Interim Analysis of Ganaxolone
Marinus Pharmaceuticals Shares Fall After Phase 3 Trial Interim Analysis of Ganaxolone
Apr 15, 2024
11:49 AM EDT, 04/15/2024 (MT Newswires) -- Marinus Pharmaceuticals ( MRNS ) shares fell past 79% in recent Monday trading after the company said that a phase 3 trial of ganaxolone did not meet pre-defined stopping criteria at the interim analysis. The study was designed to evaluate intravenous ganaxolone for the treatment of refractory status epilepticus, the company said. An...
Copyright 2023-2026 - www.financetom.com All Rights Reserved